RSS   Newsletter   Contact   Advertise with us

AbbVie Q2 net revenues $10.425 billion

Christian Fernsby ▼ | August 3, 2020
AbbVie announced financial results for the second quarter ended June 30, 2020.
AbbVie
AbbVie   Net revenues from the immunology portfolio were $5.316 billion
Net revenues were $10.425 billion, an increase of 26.3 percent on a reported basis, or a decrease of 5.3 percent on a comparable operational basis.

Topics: AbbVie

Net revenues from the immunology portfolio were $5.316 billion, an increase of 8.1 percent on a reported basis, or 8.6 percent on an operational basis.

Net revenues from the hematologic oncology portfolio were $1.591 billion, an increase of 25.5 percent on a reported basis, or 25.8 percent on an operational basis.

Net revenues from the aesthetics portfolio were $481 million, a decrease of 47.9 percent on a comparable operational basis. Net revenues from the neuroscience portfolio were $734 million, an increase of over 100.0 percent on a reported basis, or 1.8 percent on a comparable operational basis.


 

MORE INSIDE POST